Dupilumab Treatment Effects in an Ethnically Diverse Population With Chronic Rhinosinusitis With Nasal Polyposis

Abroad (travel likely)Recruiting

Conditions

Chronic Rhinosinusitis With Nasal Polyps

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Montefiore Medical Center, The Bronx, New York, United States
Contact: Study coordinator (Golda Hudes, MD) · ghudes@montefiore.org · 866-633-8255
Contact: Principal Investigator (Golda Hudes, MD)

Study leads

Golda Hudes, MD
Principal Investigator
Montefiore Medical Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

BIOlogics in Severe Nasal POlyposis SurvEy.: a French Registry

Rhinosinusitis Chronic · Nasal Polyps

Abroad (travel likely)Recruiting

Lille, France · Lille, France

Effect of Dupilumab on Nasal Epithelial Barrier Function in Patients With CRSwNP

Chronic Rhinosinusitis With Nasal Polyps · Chronic Rhinosinusitis Without Nasal Polyps

Abroad (travel likely)Recruiting

Vienna, Austria

Interleukin-4Ra Blockade by Dupilumab Decreases Staphylococcus Colonization and Increases Microbial Diversity in CRSwNP

Nasal Polyps · Staphylococcus Aureus

Abroad (travel likely)RecruitingPHASE4

Charlottesville, United States

Olfactory Outcomes of Dupilumab Treatment for Nasal Polyposis

Chronic Rhinosinusitis With Nasal Polyps · Olfactory Disorder

Abroad (travel likely)RecruitingPHASE4

London, Canada